IDEXX Laboratories, Inc.  

(Public, NASDAQ:IDXX)   Watch this stock  
Find more results for IDXX
141.67
-1.19 (-0.83%)
Oct 31 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 141.54 - 144.51
52 week 101.33 - 144.51
Open 144.51
Vol / Avg. 521,124.00/663,398.00
Mkt cap 6.81B
P/E 36.79
Div/yield     -
EPS 3.85
Shares 47.68M
Beta 0.77
Inst. own 102%
Oct 24, 2014
Q3 2014 IDEXX Laboratories Inc Earnings Release
Oct 24, 2014
Q3 2014 IDEXX Laboratories Inc Earnings Call
Aug 8, 2014
IDEXX Laboratories Inc Corporate Analyst Day - Day 2
Aug 7, 2014
IDEXX Laboratories Inc Corporate Analyst Day - Day 1
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 13.60% 13.64%
Operating margin 18.82% 19.37%
EBITD margin - 23.34%
Return on average assets 16.26% 16.09%
Return on average equity 61.31% 32.54%
Employees 5,700 -
CDP Score - -

Address

One IDEXX Drive
WESTBROOK, ME 04092-2041
United States - Map
+1-207-5560300 (Phone)
+1-207-5564346 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company operates through three segments: diagnostic and information technology-based products and services for the veterinary market, which it refers to as the Companion Animal Group (CAG), water quality products (Water) and products for livestock and poultry health, which it refer to as Livestock and Poultry Diagnostics (LPD). It also operates two smaller segments that consist of products for milk quality and safety (Dairy) and products for the human point-of-care medical diagnostics market (OPTI Medical). In November 2011, the Company acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri. In August 2013, IDEXX Laboratories, Inc. announced that it has acquired Madasa do Brasil Ltda.

Officers and directors

Jonathan W. Ayers Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian P. McKeon Chief Financial Officer, Executive Vice President, Treasurer
Age: 51
Bio & Compensation  - Reuters
Jay Mazelsky Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Johnny D. Powers Ph.D. Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Michael J. Williams Ph.D. Executive Vice President
Age: 46
Bio & Compensation  - Reuters
Jacqueline L. Studer Corporate Vice President, General Counsel, Secretary
Bio & Compensation  - Reuters
William T. End Lead Independent Director
Age: 66
Bio & Compensation  - Reuters
Sophie V. Vandebroek Ph.D. Director
Age: 52
Bio & Compensation  - Reuters
Thomas Craig Independent Director
Age: 59
Bio & Compensation  - Reuters
Rebecca M. Henderson Ph.D. Independent Director
Age: 53
Bio & Compensation  - Reuters